Related Experiment Video
Updated: Jul 19, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
[Aortic valve stenosis: from valvuloplasty to percutaneous heart valve]
Stefan Sack1, Philip Kahlert, Sasan Khandanpour
1Klinik für Kardiologie, Westdeutsches Herzzentrum Essen, Zentrum für Innere Medizin, Universitätsklinikum Essen, Hufelandstrasse 55, 45122 Essen. stefan.sack@uk-essen.de
Insights
Balloon aortic valvuloplasty offers symptom relief and improved quality of life for elderly patients with calcified aortic stenosis. While not reducing mortality, new techniques like percutaneous valve replacement show promise for this common heart valve disease.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomedical Engineering
Context:
- Calcified aortic stenosis is the most common heart valve disease, primarily affecting elderly individuals.
- Patients often present with comorbidities, increasing surgical risks.
- Traditional open-heart surgery poses significant risks for this demographic.
Purpose:
- To review the current status and emerging techniques in managing calcified aortic stenosis.
- To highlight the advancements and potential of balloon aortic valvuloplasty and percutaneous valve replacement.
- To discuss the role of novel approaches in improving patient outcomes.
Summary:
- Balloon aortic valvuloplasty alleviates symptoms and enhances physical function in elderly patients but does not reduce mortality.
- Recent innovations have revitalized balloon aortic valvuloplasty, with investigations into brachytherapy to prevent restenosis.
- Percutaneous heart valves, utilizing various access routes, represent a significant advancement in treating calcified aortic stenosis, though long-term data is pending.
Impact:
- Improved quality of life and symptom management for patients with calcified aortic stenosis.
- Potential for less invasive treatment options, reducing risks associated with open-heart surgery.
- Advancements in percutaneous valve technology offer a new therapeutic avenue for a prevalent valvular heart condition.
Abstract:
Calcified aortic stenosis is the predominant valve disease. Patients affected are most commonly elderly people, who often show associated comorbidities like reduced left ventricular function, impaired renal function, and pulmonary hypertension. The risk of open-heart surgery is elevated. Balloon aortic valvuloplasty enables a reduction of symptoms, an increase in physical performance, and, therefore, an improved quality of life. However, a reduction in mortality cannot be reached with this method. New techniques and improved equipment induced a "revival" of balloon aortic valvuloplasty, which has been introduced almost 20 years ago. In addition, brachytherapy after balloon valvuloplasty has recently been investigated and represents an interesting approach to reduce early restenosis. The technical improvement of balloon valvuloplasty is the percutaneous heart valve, which is under present clinical investigation. The antegrade/transseptal and retrograde approaches are used, as is the transapical access to the left ventricle. Even if long-term results are not yet available and the procedures still require technical improvement, especially minimization of catheter size, percutaneous valve replacement is a new chapter in the treatment of the calcified aortic stenosis.
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Stenosis IV: Nursing Management
Aortic Regurgitation I: Introduction
Mitral Valve Prolapse I: Introduction

